Navigation Links
RayBiotech, Inc. Achieves Both GMP- and GLP-Compliance and Announces New Dedicated Services Laboratory

NORCROSS, Ga., Sept. 5, 2012 PRNewswire/ -- RayBiotech, Inc. today announced that the company has established formal compliance in both Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP).  Particular product lines now manufactured under GMP status include Quantibody, G-, C- and L-Series antibody arrays as well as all ELISA-related products, but the compliance under GMP guidelines will apply to all products developed, manufactured and sold by the company.  GLP-compliance will apply to the performance of all biological sample analysis services.  Related to this, RayBiotech also announced the recent construction and launch of a new GLP-compliant laboratory that will be dedicated exclusively to the implementation of ELISA and antibody array biomarker analysis services for its clients.  These services will be available to the pharmaceutical, biopharmaceutical, biotechnology and non-profit/academic research communities and will include full biochemical and bioinformatics/biostatistics-related analyses.   

RayBiotech's President, COO and Co-founder, Rani Huang, commented, "We have always stood behind the quality of our products and services and RayBiotech's recent attainment of both GMP- and GLP-compliance only further validates our high standards.  We look forward to developing and manufacturing products as well as providing analytical services under these new stringent guidelines."

About RayBiotech, Inc.
RayBiotech ( pioneered the development of antibody and protein array technologies and provides reliable high-throughput platforms for identifying disease mechanisms, screening and validation of novel biomarkers and identification of new drug targets.  In 2001, RayBiotech introduced the first commercially available cytokine antibody array. Since then, RayBiotech array products have been featured in hundreds of publications, including some in top-tier journals: Nature, Nature Medicine, Cell, Lancet, PNAS (USA), and many others. Offering more antibody array choices than any of its competitors, RayBiotech has established a leading reputation for high quality and innovative developments in the research community. RayBiotech continues to lead in the development of protein array technologies and is focused on further meeting the needs of clients in translating new knowledge of human biology to improved health. A spin-off from Emory University's School of Medicine, RayBiotech is privately owned, with headquarters in metropolitan Atlanta (Norcross, GA).

For More Information:

Rob Burgess, PhD
Director, Business Development
RayBiotech, Inc.
Phone: 770-729-2992


SOURCE RayBiotech, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. RayBiotech, Inc. and the University of Oslo Enter into Antibody Array Services Collaboration
2. RayBiotech, Inc. Announces New Diagnostic Core Facility Partnering Program
3. AtheroNova Achieves Milestone in Initiating First Shipment of AHRO-001
4. GenVec Achieves Second Milestone in Collaboration
5. Tufts Medical Center Announces Inaugural INNOVATION Day: Innovating a Path to Market
6. ESTEVE Announces the Publication of Comprehensive Phase I Data for a Novel Oral, First-in-class New Chemical Entity (NCE),E-52862, a Sigma-1 Receptor Antagonist (S1RA) Being Developed for Pain
7. Texas Medical Center, the largest concentration of medical research, educational and healthcare organizations in the world, announces the first Houston Stem Cell Summit to highlight the latest stem cell research and commercialization efforts
8. Sangamo BioSciences Announces Presentation At The Stifel Nicolaus 2012 Healthcare Conference
9. ARMGO Pharma, Inc. announces data which supports its Rycal program as a novel approach for the treatment of stress-induced cognitive disorders
10. Bolder BioTechnology Announces Publication of Data Demonstrating Utility of the Companys Long-Acting IL-11 Analog to Prevent Renal Ischemia Reperfusion Injury
11. Clinical Site Services, Industry Leader in Patient Enrollment Solutions, Announces New Website
Post Your Comments:
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... pathology, announced today it will be hosting a Webinar titled, “Pathology is going ... Pathology Associates , on digital pathology adoption best practices and how Proscia improves ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... implantation and pregnancy rates in frozen and fresh in vitro fertilization (IVF) ... and maternal age to IVF success. , After comparing the results from the ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... program has won a US2020 STEM Mentoring Award. Representatives of the FirstHand program ... in Volunteer Experience from US2020. , US2020’s mission is to change the trajectory ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... optimization firm for the life sciences and healthcare industries, announces a presentation by ... Francisco. , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present ...
Breaking Biology Technology:
(Date:8/23/2017)... -- The general public,s help is being enlisted in what,s thought to be ... on the human body –and are believed to affect health.  ... The Microbiome Immunity Project is the largest study ... gut. The project's goal is to help advance scientific knowledge of the ... ...
(Date:7/20/2017)... WASHINGTON , July 20, 2017 Delta (NYSE: ... to board any Delta aircraft at Reagan Washington National Airport (DCA). ... Delta launches biometrics ... Delta,s ... Delta Sky Club is now integrated into the boarding process to ...
(Date:6/23/2017)... ARMONK, N.Y. and ITHACA, N.Y. ... IBM ) and Cornell University, a leader in dairy ... combined with bioinformatics designed to help reduce the chances ... breaches. With the onset of this dairy project, Cornell ... the Consortium for Sequencing the Food Supply Chain, a ...
Breaking Biology News(10 mins):